Template:Labeltemplate: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #000000;" align=left | [[{{BASEPAGENAME}}/black box warning|{{fontcolor|#FF0000|Black Box Warning}}]]
! style="font-size: 80%; padding: 0 5px; background: #000000;" align=left | [[{{BASEPAGENAME}}/black box warning|{{fontcolor|#FF0000|Black Box Warning}}]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/overview|Overview]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/adult indications and dosage|Adult Indications and Dosage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/adult indications and dosage|Adult Indications and Dosage]]
Line 20: Line 22:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/use in specific populations|Use in Specific Populations]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/use in specific populations|Use in Specific Populations]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/routes and preparations|Routes and Preparations]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/mechanism of action|Mechanism of Action]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/mechanism of action|Mechanism of Action]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/forms and administration|Forms and Administration]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/IV compatibility|IV Compatibility]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/IV compatibility|IV Compatibility]]
Line 37: Line 40:
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/images|Images]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/images|Images]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/patient counseling information|Patient Counseling Information]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/patient information|Patient Information]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/look-alike drug names|Look-Alike Drug Names]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/look-alike drug names|Look-Alike Drug Names]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/price|Price]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/price|Price]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC;" align=left | [[{{BASEPAGENAME}}/drug shortage|Drug Shortage]]
|-
|-
|}
|}

Revision as of 16:40, 18 March 2014